| For: | Asghar K, Farooq A, Zulfiqar B, Loya A. Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase. World J Clin Oncol 2021; 12(6): 429-436 [PMID: 34189067 DOI: 10.5306/wjco.v12.i6.429] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i6/429.htm |
| Number | Citing Articles |
| 1 |
Pratyasha Sarangi. Role of indoleamine 2, 3-dioxygenase 1 in immunosuppression of breast cancer. Cancer Pathogenesis and Therapy 2024; 2(4) doi: 10.1016/j.cpt.2023.11.001
|
| 2 |
Yidi Jiang, Chaofan Zhao, Qi Qiu, Qin Feng, Le Yang, Zhengcan Zhou, Mingqian Jia, Huiru Liao, Qinnan Li, Ye Sun, Jianjun Gu, Bo Yang, Ning Zhang, Hui Sun. Metabolomics-based exploration of the pathogenesis of breast cancer-related fatigue and progress of traditional Chinese medicine intervention. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1702291
|
| 3 |
Mostafa Rahvar, Leila Gholami, Mahya Rahmani. Immunomodulatory Biomaterials and Nano-immunotherapies. 2025; doi: 10.1016/B978-0-443-21521-6.00004-1
|
| 4 |
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Túlio Teruo Yoshinaga, Maria Lucia Zaidan Dagli, Cristina de Oliveira Massoco, Jose Roberto Kfoury Junior. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. Molecular Biology Reports 2023; 50(7) doi: 10.1007/s11033-023-08469-3
|
| 5 |
Nikolaos Syrigos, Alexandros Mougiakos, Anastasia Konstantinidou, Emmanouil Panagiotou, Anastasia Karachaliou, Eleni Fyta, Ioannis Vamvakaris, Evangelia Karagianni, Elias Kotteas, Sophocles Lanitis, Christos Markopoulos, Theodoros Troupis, Dimitra Grapsa. Immunohistochemical Expression of IDO and PD-L1 in Distinct Compartments of Breast Cancer Tissue: Correlation with Clinicopathological Features and Outcomes. Cancers 2026; 18(7) doi: 10.3390/cancers18071180
|
| 6 |
Yinan Ding, Luhong Wang, Han Li, Fengqin Miao, Zhiyuan Zhang, Chunmei Hu, Weiping Yu, Qiusha Tang, Guoliang Shao. Application of lipid nanovesicle drug delivery system in cancer immunotherapy. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01429-2
|
| 7 |
Hua Yang, Yongjun Liu. RETRACTED: Kinesin Family Member 2A Serves as a Potential Biomarker Reflecting More Frequent Lymph Node Metastasis and Tumor Recurrence Risk in Basal-Like Breast Cancer Patients. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.889294
|
| 8 |
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Túlio Teruo Yoshinaga, Cristina de Oliveira Massoco, Jose´ Roberto Kfoury Junior. IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells. Immunologic Research 2023; 71(5) doi: 10.1007/s12026-023-09378-0
|
| 9 |
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Mohammad Soleiman Ekhtiyari, Jose Roberto Kfoury Junior. Landscape of unconventional γδ T cell subsets in cancer. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09267-1
|